Singing rehab supports speech recovery, caregiver well-being after stroke: study
By
Alicia Lasek
Jan 04, 2023
Singing-based group rehabilitation not only supports communication and speech production in stroke survivors with aphasia, but benefits caregivers as well, investigators say.
Functional impairment from COVID-19 may persist long after ICU discharge, studies suggest
By
Alicia Lasek
Jul 21, 2021
Certain physical and mental health problems persist for years in some hospitalized survivors of acute respiratory diseases, suggesting that disability may be permanent for some severely ill COVID-19 patients...
Show us the data: COVID vaccine boosters may get go-ahead, but LTC docs remain wary
By
Alicia Lasek
Danielle Brown
Aug 09, 2021
Booster shots for the most vulnerable appear to be on a fast track to federal authorization. But clinicians want information about necessity, safety, dosing and more to justify prescribing an extra dose...
In a first, FDA advisers endorse vaccines to prevent RSV in older adults
By
Alicia Lasek
Mar 01, 2023
In landmark decisions, the advisers recommended that two new vaccines for respiratory syncytial virus (RSV) should be approved for use in older adults.
CDC: C. auris spreading at ‘alarming’ rate in U.S. healthcare facilities
By
Alicia Lasek
Mar 22, 2023
Drug-resistant Candida auris, a known threat to nursing homes, has spread rapidly, and a growing number of cases are resistant to first-line treatment, federal researchers report.
Feds’ antipsychotics program fails to reduce prescriptions in assisted living
By
Alicia Lasek
Aug 23, 2022
In a federal initiative to reduce unnecessary antipsychotics prescribing, results in assisted living didn’t match the successes seen in nursing homes, a new study reveals.
COVID vaccine protection drops by 80 percent in 6 months among nursing home residents: study
By
Alicia Lasek
Sep 03, 2021
Vaccinated staff members had a similar six-month decrease in immunity levels, investigators say. The data may support recommendations for vaccine booster shots, they contend.
Treating rare blood clots related to J&J COVID vaccine following usage suspension: new guidance
By
Alicia Lasek
Apr 28, 2021
Advisers to the CDC have released new clinical guidance and education regarding a rare blood clotting condition reported after vaccination.
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Feds wait for lowered vaccine efficacy to recommend COVID-19 booster shots
By
Alicia Lasek
Jul 22, 2021
COVID-19 vaccine booster shots will not be necessary until mRNA vaccines become less effective, federal health officials say. But immunocompromised Americans are potential near-term recipients, they told...